April 13 (Reuters) - Deinove SA:
* DEINOVE TAKES ON A WHOLE NEW DIMENSION WITH THE ACQUISITION OF MORPHOCHEM’S CLINICAL-STAGE ANTIBIOTIC COMPOUND
* DEINOVE SA- ANNOUNCES ACQUISITION, THROUGH A CONTRIBUTION-IN-KIND TRANSACTION, OF ENTIRE CAPITAL OF AUSTRIAN COMPANY BIOVERTIS AG
* DEINOVE SA- BIOVERTIS OWNS ENTIRE CAPITAL OF GERMAN COMPANY MORPHOCHEM, WITH LATTER DEVELOPING CLINICAL-STAGE ANTIBIOTIC COMPOUND “MCB3837” Source text for Eikon: Further company coverage:
